AusBiotech announces Australasian Life Science Investment Summit
17 March, 2010 by Staff WritersFollowing success from last year, AusBiotech will hold another investment summit in October.
Targeted antibiotics tackle bacterial resistance
16 March, 2010 by Staff WritersA new approach to combating antibiotic resistance draws on lessons learned from targeted therapies for cancer.
ResMed slapped with anti-trust suit in US
15 March, 2010 by Tim DeanResMed and rival challenged by disgruntled distributor over access to products.
Australian biotech market watch 15/03/10
15 March, 2010 by Tim DeanLiving Cell Technology, Ansell, ChemGenex, Biota Holdings, Sonic Healthcare, ResMed, CSL
Feature: Centre for Kinomics shakes up drug discovery
12 March, 2010 by Tim DeanAdam McCluskey and Phillip Robinson are embarking on an ambitious project that could radically change the way drug research is conducted in Australia.
Aim Lab launches Tecan Australian venture
12 March, 2010 by Tim DeanTecan Australia to provide Tecan laboratory instruments and support in Oceania through AimLab.
Living Cell Technologies implant given regulatory tick in Russia
10 March, 2010 by Tim DeanBrings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
Agilent Technologies announces strategic partnership with Pacific Laboratory Products in Australia
08 March, 2010 by Staff WritersStrategic partnership will offer best-in-class support and efficient delivery of Agilent Columns and Supplies products.
Cobra venom reveals novel neurotoxin
08 March, 2010 by Tim DeanProtein in king cobra venom could lead to development of new therapeutics or molecular probes.
BIO 2010: Marinova shares sea’s bounty
05 March, 2010 by David BinningThe sight of brown seaweed is not one that would normally have people seeing dollar signs, but for Hobart-based Marinova, its solvent-free technique for extracting the coveted element fucoidan from an introduced species of sea-flora in Tasmania has made it one of Australia’s most promising up and coming biotechs.
IVD legislation goes live amidst industry concern
04 March, 2010 by Tim DeanIn vitro diagnostics legislation has passed into law although the industry still has reservations about compliance costs.
Stirling snaps up Canadian drug manufacturing plant for a song
03 March, 2010 by Staff Writers$20 million state-of-the-art manufacturing facility acquired for $3.85 million.
Bionomics announces positive results in phase Ia trial of anti-stress drug
02 March, 2010 by Staff WritersFinal results of phase Ia trial of BNC210 announced demonstrating safety and efficacy.
HalcyGen sees success in SUBA-Itraconazole study
02 March, 2010 by Staff WritersPreliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox.
BioProspect consolidates deal with Solagran
26 February, 2010 by Staff WritersSolagran and BioProspect to develop commercialisation plan for animal health and nutrition products.
